CONTRAINDICATIONS SECTION.
CONTRAINDICATIONS: PNV-DHA is contraindicated in patients with known hypersensitivity to any of the ingredients.
Citing DrugCentral © 2026. License
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL.
PRINCIPAL DISPLAY PANEL 30 Softgel Tablets. NDC 42192-321-30PNV-DHARx Prenatal Vitamin and DHARx Only 30 SoftgelsAcella PHARMACEUTICALS, LLC Bottle Label.
Citing DrugCentral © 2026. License
PRECAUTIONS SECTION.
PRECAUTIONS: Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where Vitamin 12 is deficient. Folic acid in doses above 1.0 mg daily may obscure pernicious anemia in that hematologic remission can occur while neurological manifestations progress.
Citing DrugCentral © 2026. License
SPL UNCLASSIFIED SECTION.
Rx OnlyDietary Supplement.
Citing DrugCentral © 2026. License
DESCRIPTION SECTION.
DESCRIPTION: PNV-DHA is prescription prenatal/postnatal multivitamin/mineral/essential fatty acid softgel. Each softgel is cobalt blue in color, opaque and imprinted with BP 321 on one side and blank on the other. PNV-DHA can also be beneficial in improving the nutritional status of women prior to conception. Supplement Facts Panel. PNV-DHA contains fish oil and soy.OTHER INGREDIENTS: Beeswax, soy lecithin and vegetable shortening. Coating contains: Bovine gelatin, FD&C Blue No. 1, FD&C Red No. 3, glycerin, purified water and titanium dioxide. Contains Soy. INDICATIONS: PNV-DHA is multivitamin/multimineral fatty acid dietary supplement indicated for use in improving the nutritional status of women throughout pregnancy and in the postnatal period for both lactating and nonlactating mothers. CONTRAINDICATIONS: PNV-DHA is contraindicated in patients with known hypersensitivity to any of the ingredients.
Citing DrugCentral © 2026. License
DOSAGE & ADMINISTRATION SECTION.
DOSAGE AND ADMINISTRATION: Before, during and/or after pregnancy, one softgel daily or as directed by physician.
Citing DrugCentral © 2026. License
HOW SUPPLIED SECTION.
HOW SUPPLIED: Bottles of 30 softgels (42192-321-30). The listed product number is not National Code. Instead, Acella Pharmaceuticals has assigned product code formatted according to standard industry practice to meet the formatting requirements of pharmacy and healthcare insurance computer systems. STORAGE: Store at 20 25C (68 77F); excursions permitted to 15 30C (59 86F) [See USP Controlled Room Temperature.].
Citing DrugCentral © 2026. License
INACTIVE INGREDIENT SECTION.
PNV-DHA contains fish oil and soy.OTHER INGREDIENTS: Beeswax, soy lecithin and vegetable shortening. Coating contains: Bovine gelatin, FD&C Blue No. 1, FD&C Red No. 3, glycerin, purified water and titanium dioxide. Contains Soy.
Citing DrugCentral © 2026. License
INDICATIONS & USAGE SECTION.
INDICATIONS: PNV-DHA is multivitamin/multimineral fatty acid dietary supplement indicated for use in improving the nutritional status of women throughout pregnancy and in the postnatal period for both lactating and nonlactating mothers.
Citing DrugCentral © 2026. License
ADVERSE REACTIONS SECTION.
ADVERSE REACTIONS: Allergic sensitization has been reported following both oral and parenteral administration of folic acid.
Citing DrugCentral © 2026. License
BOXED WARNING SECTION.
WARNING: Ingestion of more than grams of omega-3 fatty acids (such as DHA) per day has been shown to have potential antithrombotic effects, including an increased bleeding time and International Normalized Ratio (INR). Administration of omega-3 fatty acids should be avoided in patients taking anticoagulants and in those known to have an inherited or acquired predisposition to bleeding.
Citing DrugCentral © 2026. License